The Role of 11Beta-Hydroxysteroid Dehydrogenase in Metabolic Disease and Therapeutic Potential of 11Beta-HSD1 Inhibitors

By  

Current Medicinal Chemistry, Vol. 15, Iss. 7, 2008-03 ,pp. : 642-649

Bentham Science Publishers

Access to resources Recommend Favorite

Development of 11&bgr; -HSD1 Inhibitors for the Treatment of Type 2 Diabetes

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-06 ,pp. : 702-710

Bentham Science Publishers

Access to resources Recommend Favorite

Type 1 11 &bgr;-hydroxysteroid Dehydrogenase as Universal Drug Target in Metabolic Diseases?

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 3, 2006-09 ,pp. : 259-269

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR)&bgr; /&dgr;: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome

By  

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 46-55

Bentham Science Publishers

Access to resources Recommend Favorite

Tissue-Specific Glucocorticoid Reactivating Enzyme, 11#946;-Hydroxysteoid Dehydrogenase Type 1 (11#946;-HSD1) - A Promising Drug Target for the Treatment of Metabolic Syndrome

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 255-262

Bentham Science Publishers

Access to resources Recommend Favorite